The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Epanutin 30 mg/5ml Oral Suspension

Upjohn EESVPA23055/003/007

Main Information

Trade NameEpanutin 30 mg/5ml Oral Suspension
Active SubstancesPhenytoin
Dosage FormOral suspension
Licence HolderUpjohn EESV
Licence NumberPA23055/003/007

Group Information

ATC CodeN03AB Hydantoin derivatives
N03AB02 phenytoin


License statusAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back